Misitura Arowona, a postgraduate student in the Department of Chemistry, University of Ilorin, has developed a drug that promises to have a strong effect in the treatment of tuberculosis, an infectious disease that usually attacks the lungs.
According to the institution’s weekly Bulletin on Monday, Arowona who is being supervised by Prof. Joshua Obaleye, former Dean, Faculty of Science of UNILORIN, was currently undergoing a sandwich fellowship at the Faculty of Science of the Maharaja Sayajirao University, Vadodara, India.
The News Agency of Nigeria (NAN) also reports that the metal attached anti-TB drug developed by Arowona has improved the efficiency of the anti-TB drugs compared to normal drugs that are consumed globally.
The weekly bulletin also made it known that Nigeria was among the fourteen high burden countries for TB, TB/HIV and multi-drug resistant TB.
“The country is ranked 17th among the 30 high TB burden countries and second in Africa and the problem of TB in Nigeria has been made worse by the issues of drug-resistent TB and the HIV/AIDS.
“It is estimated that about 407,000 people in Nigeria have TB in a year,” the weekly bulletin stated.
The publication explained that Arowona stated that earlier studies have proved that when a metal is attached with a pharmaceutical, it increases the efficacy of the drug.
“Taking a cue from cisplatin, an anti-cancer drug, whose efficacy improved after applying platinum as metal, the scholar worked on multiple metal-based drugs to see whether the efficiency of anti-TB drugs can be increased by attaching metals to it”.